Detalhe da pesquisa
1.
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.
Hum Mutat
; 40(11): e1-e23, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209999
2.
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.
Hum Mutat
; 40(10): 1781-1796, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112363
3.
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Hum Mutat
; 39(5): 593-620, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446198
4.
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Breast Cancer Res
; 18(1): 112, 2016 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836010
5.
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 148(2): 397-406, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311111
6.
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.
Breast Cancer Res Treat
; 124(1): 195-203, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20180014
7.
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
JAMA
; 304(9): 967-75, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20810374
8.
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.
Cancer Res
; 80(3): 624-638, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723001
9.
Validity of models for predicting BRCA1 and BRCA2 mutations.
Ann Intern Med
; 147(7): 441-50, 2007 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-17909205
10.
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Clin Breast Cancer
; 7(11): 875-82, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18269778
11.
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
JAMA Oncol
; 2(11): 1434-1440, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27367496
12.
Active recruitment increased enrollment in a hereditary cancer registry.
J Clin Epidemiol
; 57(11): 1172-6, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15567634
13.
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.
J Natl Cancer Inst
; 106(6): dju091, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24824314
14.
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.
J Clin Oncol
; 30(12): 1321-8, 2012 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22430266
15.
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.
Cancer Res
; 71(17): 5792-805, 2011 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21799032
16.
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
Cancer Res
; 69(14): 5801-10, 2009 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19584272
17.
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
J Clin Oncol
; 26(8): 1331-7, 2008 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18268356
18.
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Lancet Oncol
; 7(3): 223-9, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16510331